154 related articles for article (PubMed ID: 20652713)
61. Supported liquid extraction (SLE) for the analysis of methylamphetamine, methylenedioxymethylamphetamine and delta-9-tetrahydrocannabinol in oral fluid and blood of drivers.
Rositano J; Harpas P; Kostakis C; Scott T
Forensic Sci Int; 2016 Aug; 265():125-30. PubMed ID: 26878366
[TBL] [Abstract][Full Text] [Related]
62. Oral Fluid Testing for Cocaine: Analytical Evaluation of Two Point-of-Collection Drug Screening Devices.
Scherer JN; Fiorentin TR; Sousa TRV; Limberger RP; Pechansky F
J Anal Toxicol; 2017 Jun; 41(5):392-398. PubMed ID: 28334841
[TBL] [Abstract][Full Text] [Related]
63. Toxicological oral fluid results among Spanish drivers testing positive on on-site drug controls from 2013 to 2015.
Lema-Atán JÁ; de Castro A; Lendoiro E; López-Rivadulla M; Cruz A
Drug Alcohol Depend; 2019 Feb; 195():106-113. PubMed ID: 30611978
[TBL] [Abstract][Full Text] [Related]
64. Drugged Driving in Wisconsin: Oral Fluid Versus Blood.
Edwards LD; Smith KL; Savage T
J Anal Toxicol; 2017 Jul; 41(6):523-529. PubMed ID: 28830121
[TBL] [Abstract][Full Text] [Related]
65. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
Truver MT; Palmquist KB; Swortwood MJ
J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
[TBL] [Abstract][Full Text] [Related]
66. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
Johnson-Davis KL; Sadler AJ; Genzen JR
J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
[TBL] [Abstract][Full Text] [Related]
67. Drug driving in Italy. The results of the first roadside drug testing service utilizing on-site confirmatory analysis between 2019 and 2022.
Poetto AS; Catesini G; Dossetto P; Marchetti S; Addobbati R
Forensic Sci Int; 2024 Feb; 355():111929. PubMed ID: 38262308
[TBL] [Abstract][Full Text] [Related]
68. Smoke on the water-Oral fluid analysis at sea.
Griffiths A; Leonars R; Hadley L; Stephenson M; Teale R
Forensic Sci Int; 2017 Sep; 278():361-366. PubMed ID: 28802951
[TBL] [Abstract][Full Text] [Related]
69. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
Ros JJ; Pelders MG; Egberts AC
J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
[TBL] [Abstract][Full Text] [Related]
70. Fiber spray ionization mass spectrometry in forensic chemistry: A screening of drugs of abuse and direct determination of cocaine in urine.
Filho JFA; Dos Santos NA; Borges KB; Lacerda V; Pelição FS; Romão W
Rapid Commun Mass Spectrom; 2020 Sep; 34 Suppl 3():e8747. PubMed ID: 32056289
[TBL] [Abstract][Full Text] [Related]
71. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.
ElSohly MA; Stanford DF; Murphy TP; Lester BM; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HC
J Anal Toxicol; 1999 Oct; 23(6):436-45. PubMed ID: 10517548
[TBL] [Abstract][Full Text] [Related]
72. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
[TBL] [Abstract][Full Text] [Related]
73. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.
Cooper G; Wilson L; Reid C; Main L; Hand C
Forensic Sci Int; 2005 Jun; 150(2-3):239-43. PubMed ID: 15944065
[TBL] [Abstract][Full Text] [Related]
75. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
[TBL] [Abstract][Full Text] [Related]
76. Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results.
Desrosiers NA; Huestis MA
J Anal Toxicol; 2019 Jul; 43(6):415-443. PubMed ID: 31263897
[TBL] [Abstract][Full Text] [Related]
77. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
Cone EJ; Presley L; Lehrer M; Seiter W; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS
J Anal Toxicol; 2002; 26(8):541-6. PubMed ID: 12501910
[TBL] [Abstract][Full Text] [Related]
78. [Evaluation of six rapid tests for screening of cannabis in sweat, saliva and tears].
Mura P; Kintz P; Papet Y; Ruesch G; Piriou A
Acta Clin Belg; 1999; 53 Suppl 1():35-8. PubMed ID: 10216980
[TBL] [Abstract][Full Text] [Related]
79. Suitability of SoToxa® Oral Fluid Screening Over Time: Re-Examination of Drugged Driving in Wisconsin.
Savage T; Sanders T; Pieters R; Miles A; Barkholtz H
J Anal Toxicol; 2022 Oct; 46(8):825-834. PubMed ID: 35767245
[TBL] [Abstract][Full Text] [Related]
80. [Clinical and analytical toxicology of opiate, cocaine and amphetamine].
Feliu C; Fouley A; Millart H; Gozalo C; Marty H; Djerada Z
Ann Biol Clin (Paris); 2015; 73(1):54-69. PubMed ID: 25582723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
